AURAAura BiosciencesSigning up patients
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Eye Cancer · Primary Cancer
6Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +5.5
Announced layoffs or restructuring
Since Aug 11, 2026 · was worth 15, fading over time
Worry score6
Score over time
- Stage
- Phase 2
- Patients
- 24 (planned)
- Started
- Dec 16, 2024
- Main results expected
- Nov 30, 2026
- Fully finished
- Oct 31, 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Change from baseline in choroidal tumor thickness on B-scan ultrasonography (B-scan) 4 weeks after completion of treatment.
Measured over: 4 weeks after completion of treatment
Change from baseline in choroidal tumor largest basal diameter (LBD) on fundus photos 4 weeks after completion of treatment.
Measured over: 4 weeks after completion of treatment
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- layoffs: base 15, now 5.5, since 2026-08-11, fades (half-life) · source filing
Raw record changes
- none yet
Trial ID NCT06643884 · record last updated 2026-10-08 · checked 2026-11-09 15:47 UTC